Nitric oxide is required for effective innate immunity against Klebsiella pneumoniae
about
Dexamethasone impairs pulmonary defence against Pseudomonas aeruginosa through suppressing iNOS gene expression and peroxynitrite production in miceLeukotrienes enhance the bactericidal activity of alveolar macrophages against Klebsiella pneumoniae through the activation of NADPH oxidaseHeterogeneity of lung mononuclear phagocytes during pneumonia: contribution of chemokine receptorsCytokine kinetics and other host factors in response to pneumococcal pulmonary infection in miceTherapeutic effects of nitric oxide inhibition during experimental fecal peritonitis: role of interleukin-10 and monocyte chemoattractant protein 1.Immunomodulation of pneumococcal pulmonary infection with N(G)-monomethyl-L-arginine.In vivo blockage of nitric oxide with aminoguanidine inhibits immunosuppression induced by an attenuated strain of Salmonella typhimurium, potentiates Salmonella infection, and inhibits macrophage and polymorphonuclear leukocyte influx into the spleSurfactant protein D enhances phagocytosis and killing of unencapsulated phase variants of Klebsiella pneumoniaeRole of macrophages in early host resistance to respiratory Acinetobacter baumannii infection.c-di-GMP enhances protective innate immunity in a murine model of pertussisLipoteichoic acid-induced nitric oxide production depends on the activation of platelet-activating factor receptor and Jak2.Myeloperoxidase produces nitrating oxidants in vivo.Effect of arginase inhibition on pulmonary L-arginine metabolism in murine Pseudomonas pneumoniaCarbapenem-resistant Klebsiella pneumoniae exhibit variability in capsular polysaccharide and capsule associated virulence traitsCyclic di-GMP stimulates protective innate immunity in bacterial pneumoniaProstaglandin E2 suppresses bacterial killing in alveolar macrophages by inhibiting NADPH oxidaseA novel nitro-dexamethasone inhibits agr system activity and improves therapeutic effects in MRSA sepsis models without antibiotics.Bacterial clearance in septic mice is modulated by MCP-1/CCL2 and nitric oxide.Heroin-induced conditioned immunomodulation requires expression of IL-1β in the dorsal hippocampus.p53 Integrates host defense and cell fate during bacterial pneumoniaIncreased susceptibility to Klebsiella pneumonia and mortality in GSNOR-deficient mice.Influence of cefodizime on pulmonary inflammatory response to heat-killed Klebsiella pneumoniae in mice.Noncapsulated Klebsiella pneumoniae bearing mannose-containing O antigens is rapidly eradicated from mouse lung and triggers cytokine production by macrophages following opsonization with surfactant protein DRedundant and cooperative interactions between TLR5 and NLRC4 in protective lung mucosal immunity against Pseudomonas aeruginosa.Inhaled fluticasone propionate impairs pulmonary clearance of Klebsiella pneumoniae in mice.
P2860
Q28363675-A255E266-9DD7-4F03-8D83-BEE10FAE7A6CQ28574027-4FF36E0A-9431-42A4-96F3-8E100495DE4EQ30409523-5859EB98-9BCB-4F8D-A3A3-C50D6B736687Q33501805-F8A81031-823C-4CF7-9B3A-E27CA9C6609FQ33750360-2141CE69-6132-4614-8094-EBAEAAA9DD2DQ33977703-26F7FAE9-2367-49CE-8C4C-80A4778387EBQ34000401-04BB39F3-DF1A-4CE8-8800-A9FB7170B27BQ34005460-B09AA012-7539-487F-BC6E-F8F5EE34F540Q34328536-6AEEC8BE-8EEB-4BF6-A42A-7D61445E6910Q34343647-AB848D4C-8A3E-4124-A830-28A82C40F65CQ34345175-7B79DA20-B164-4FD9-A29E-D32CDD044C17Q34791672-C44D6273-70E4-4B85-B320-00999D2A7196Q35111227-BC7ABE55-FA97-4318-8C5D-CD2632DD1D81Q35608370-55CEDA99-E88E-4384-A1CF-5557E699CD30Q36097274-D2013213-ABA2-411D-A319-EC5C0765EFA1Q36102855-862C665C-2109-498E-9F5A-FB13EDB835A7Q36536023-7001661A-21CF-41C0-B9DE-CEE30D772E1BQ36668647-4EB64335-5CB5-4651-9044-15BCF30E5690Q36809138-404FB2D3-F54F-4571-8B20-05DB6DAA0418Q36822702-20F652B8-1FFF-472D-B778-5F4FD61E214EQ37452579-DC893CF3-FB6B-4840-BB6B-7B9FE17314A6Q39471780-E8E404B5-EE0F-4524-BC9F-338D6C8650D1Q40380146-0FC8ED3D-DC88-40DF-976C-61334EAA0DC2Q41658682-7249BDC1-B31C-4CEA-BE44-5CD2A29E5E51Q42150942-AF664C03-8B6F-47EE-81D8-D268CA744C57
P2860
Nitric oxide is required for effective innate immunity against Klebsiella pneumoniae
description
1997 nî lūn-bûn
@nan
1997 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
1997 թվականի մայիսին հրատարակված գիտական հոդված
@hy
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
name
Nitric oxide is required for effective innate immunity against Klebsiella pneumoniae
@ast
Nitric oxide is required for effective innate immunity against Klebsiella pneumoniae
@en
type
label
Nitric oxide is required for effective innate immunity against Klebsiella pneumoniae
@ast
Nitric oxide is required for effective innate immunity against Klebsiella pneumoniae
@en
prefLabel
Nitric oxide is required for effective innate immunity against Klebsiella pneumoniae
@ast
Nitric oxide is required for effective innate immunity against Klebsiella pneumoniae
@en
P2093
P2860
P1476
Nitric oxide is required for effective innate immunity against Klebsiella pneumoniae
@en
P2093
D A Zisman
J M Wilkowski
K A Bucknell
R M Strieter
T J Standiford
P2860
P304
P407
P577
1997-05-01T00:00:00Z